AU3967593A - Method of intraoperatively detecting and locating tumoral tissues - Google Patents

Method of intraoperatively detecting and locating tumoral tissues

Info

Publication number
AU3967593A
AU3967593A AU39675/93A AU3967593A AU3967593A AU 3967593 A AU3967593 A AU 3967593A AU 39675/93 A AU39675/93 A AU 39675/93A AU 3967593 A AU3967593 A AU 3967593A AU 3967593 A AU3967593 A AU 3967593A
Authority
AU
Australia
Prior art keywords
group
peptide
peptide compound
labelled
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39675/93A
Other languages
English (en)
Inventor
Bareld Jan Doedens
Geert Jacob Ensing
Karel Jan Panek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Medical Inc filed Critical Mallinckrodt Medical Inc
Publication of AU3967593A publication Critical patent/AU3967593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AU39675/93A 1992-03-25 1993-03-24 Method of intraoperatively detecting and locating tumoral tissues Abandoned AU3967593A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92200848 1992-03-25
EP92200848 1992-03-25

Publications (1)

Publication Number Publication Date
AU3967593A true AU3967593A (en) 1993-10-21

Family

ID=8210503

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39675/93A Abandoned AU3967593A (en) 1992-03-25 1993-03-24 Method of intraoperatively detecting and locating tumoral tissues

Country Status (5)

Country Link
EP (1) EP0636032A1 (fr)
JP (1) JPH07505621A (fr)
AU (1) AU3967593A (fr)
CA (1) CA2131315A1 (fr)
WO (1) WO1993018797A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022341A1 (fr) * 1994-02-18 1995-08-24 Mallinckrodt Medical, Inc. Composes peptidiques marques
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
AUPO066096A0 (en) * 1996-06-26 1996-07-18 Peptide Delivery Systems Pty Ltd Oral delivery of peptides
US6312661B1 (en) * 1997-02-03 2001-11-06 Mallinckrodt Inc. Method for the detection and localization of ductal exocrine pancreas tumours
CA2341489A1 (fr) * 1998-09-25 2000-04-06 Mallinckrodt, Inc. Radioligand recepteur de la somatostatine, a absorption amelioree
US6331703B1 (en) 1999-03-12 2001-12-18 Ethicon Endo-Surgery, Inc. Guidance method for radiation detection
US6167297A (en) * 1999-05-05 2000-12-26 Benaron; David A. Detecting, localizing, and targeting internal sites in vivo using optical contrast agents
CN102174102A (zh) 2003-05-15 2011-09-07 塔夫茨大学信托人 肽和多肽药物的稳定类似物
CN100475271C (zh) 2003-08-20 2009-04-08 加利福尼亚大学董事会 具有抑制生长激素释放活性的促生长素抑制素类似物
CN101262874A (zh) 2005-09-08 2008-09-10 塔夫茨大学信托人 稳定化的glp-1类似物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
WO1991001144A1 (fr) * 1989-07-20 1991-02-07 Sandoz Ltd Derives de polypeptide etiquetes

Also Published As

Publication number Publication date
CA2131315A1 (fr) 1993-09-30
JPH07505621A (ja) 1995-06-22
WO1993018797A1 (fr) 1993-09-30
EP0636032A1 (fr) 1995-02-01

Similar Documents

Publication Publication Date Title
EP0804252B1 (fr) Agents chelateurs metalliques renfermant thiol, diamide et monoamine
De Jong et al. Pre‐clinical comparison of [DTPA0] octreotide,[DTPA0, Tyr3] octreotide and [DOTA0, Tyr3] octreotide as carriers for somatostatin receptor‐targeted scintigraphy and radionuclide therapy
EP0759786B1 (fr) Conjugues peptide-chelate metallique se liant a la somatostatine
EP0614379B1 (fr) Peptides marqués au technetium-99m utiles en imagerie
EP0649434B1 (fr) Peptides derives de la somatostatine et marques de maniere radioactive pour imagerie et utilisations therapeutiques
EP0831938B1 (fr) Compositions de peptides radiomarques pour le ciblage specifique d'un site
Wraight et al. The use of a chelating derivative of alpha melanocyte stimulating hormone for the clinical imaging of malignant melanoma
US20110117012A1 (en) Radiolabeled gallium complexes, methods for synthesis and use for pet imaging of egfr expression in malignant tumors
JP2001511152A (ja) 悪性ヒト腫瘍の検出および位置特定法
AU657770B2 (en) Radiolabelled somatostatin derivatives, their preparation and use
EP0719790B1 (fr) Peptides chélatants des ions métalliques et leurs utilisation
AU3967593A (en) Method of intraoperatively detecting and locating tumoral tissues
JP2002516883A (ja) 近接照射療法のための放射性ヨウ素化フェノール
EP0584256B1 (fr) Composes et compositions pour la detection et la loclisation de tissus comprenant des recepteurs de neurokinine 1
US11167048B2 (en) Dual targeting ligand for cancer diagnosis and treatment
US7122622B2 (en) Peptide compounds having improved binding affinity to somatostatin receptors
US6824759B2 (en) Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy
EP0700930B1 (fr) Peptides à affinité pour des tumeurs et composés radioactifs diagnostiques et thérapeutiques les contenant
US20040185510A1 (en) Use of labelled CCK-B receptor ligands for the detection and localization of malignant human tumours
JPH07278166A (ja) テクネチウムまたはレニウム錯体製造のためのアミノジアルキル燐酸化物をベースとする非環式キレート化剤
EP0831936A1 (fr) Thiolation de peptides aux fins d'une radiodetection et d'une radiopherapie utilisant des radionuclides
Maina et al. Development of 99m Tc labelled somatostatin analogues with high affinity for somatostatin receptors